4th Quarter - Termination

THE NICKLES GROUP, LLC for MERCK & CO. INC.

Firm
Client
Income
$45,000
Expenses
—
Terminated
Dec 31, 2018

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Monitored H.R. 6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act and Continuing Appropriations Act. Monitored H.R. 695, Further Additional Continuing Appropriations Act.

LobbyistCovered position, as disclosed
STACEY HUGHES —
EMILY PORTER —

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 695 (115th), H.R. 6157 (115th)

Trade (domestic/foreign) TRD

Monitored issues related to NAFTA.

LobbyistCovered position, as disclosed
STACEY HUGHES —
RACHEL JONES HENSLER —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Executive Office of the President (EOP)

Health Issues HCR

Issues related to antimicrobials; issues related to the reauthorization of PAHPA, including S. 2852 / H.R. 6378, Pandemic All Hazards Preparedness Act of 2018.

LobbyistCovered position, as disclosed
STEPHANIE BADGER —
STACEY HUGHES —
EMILY PORTER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); Food & Drug Administration (FDA)

Bills named: H.R. 6378 (115th), S. 2852 (115th)

Medicare/Medicaid MMM

Monitored issues related to drug pricing; S. 3787, The Developing and Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2018.

LobbyistCovered position, as disclosed
STACEY HUGHES —
EMILY PORTER —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: S. 3787 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.